Acadian Asset Management LLC Akebia Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$0.86 - $1.63 $1.07 Million - $2.03 Million	-1,246,372 Reduced 23.47%	4,063,383 $4.14 Million
Q1 2024 May 10, 2024	SELL	$1.27 - $2.24 $2.04 Million - $3.6 Million	-1,605,748 Reduced 23.22%	5,309,755 $9.72 Million
Q4 2023 Feb 13, 2024	SELL	$0.8 - $1.28 $246,388 - $394,220	-307,985 Reduced 4.26%	6,915,503 $8.57 Million
Q3 2023 Nov 13, 2023	SELL	$0.87 - $1.84 $206,072 - $435,831	-236,865 Reduced 3.17%	7,223,488 $8.23 Million
Q2 2023 Aug 07, 2023	SELL	$0.51 - $1.43 $11,577 - $32,461	-22,700 Reduced 0.3%	7,460,353 $6.82 Million
Q3 2022 Nov 14, 2022	BUY	$0.3 - $0.46 $43,203 - $66,244	144,010 Added 1.96%	7,483,053 $2.37 Million
Q2 2022 Aug 09, 2022	BUY	$0.32 - $0.67 $2.35 Million - $4.92 Million	7,339,043 New	7,339,043 $2.59 Million
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $24,994 - $41,267	-10,636 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$2.83 - $4.2 $24,156 - $35,851	8,536 Added 406.48%	10,636 $40,000
Q1 2021 May 11, 2021	SELL	$2.92 - $5.06 $2.44 Million - $4.22 Million	-833,985 Reduced 99.75%	2,100 $7,000
Q4 2020 Feb 11, 2021	BUY	$2.22 - $3.78 $259,224 - $441,383	116,768 Added 16.23%	836,085 $2.34 Million
Q3 2020 Nov 09, 2020	BUY	$2.39 - $13.08 $1.71 Million - $9.36 Million	715,611 Added 19309.53%	719,317 $1.81 Million
Q2 2020 Aug 12, 2020	BUY	$6.67 - $13.58 $24,719 - $50,327	3,706 New	3,706 $50,000
Q4 2018 Feb 07, 2019	SELL	$5.39 - $9.15 $396,251 - $672,671	-73,516 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$7.44 - $10.65 $202,055 - $289,232	-27,158 Reduced 26.98%	73,516 $649,000
Q2 2018 Jul 24, 2018	SELL	$9.15 - $11.34 $1.83 Million - $2.27 Million	-199,758 Reduced 66.49%	100,674 $1.01 Million
Q1 2018 Apr 12, 2018	SELL	$9.53 - $15.68 $3.09 Million - $5.09 Million	-324,735 Reduced 51.94%	300,432 $2.86 Million
Q4 2017 Jan 18, 2018	SELL	$14.24 - $19.59 $1.47 Million - $2.02 Million	-103,062 Reduced 14.15%	625,167 $9.3 Million
Q3 2017 Oct 13, 2017	BUY	$13.06 - $19.67 $9.51 Million - $14.3 Million	728,229	728,229 $14.3 Million

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$20.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$17.7 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$10.1 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$8.37 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$6.54 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account